The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), according to The New York Times.

As part of the foreign aid freeze by President Donald Trump, the U.S. distribution of HIV drugs in poor countries has been stopped.

The President’s Emergency Plan for AIDS Relief (PEPFAR), a federal program that provides HIV medications, is one of the programs on pause during a 90-day review ordered by the Secretary of State.

In a last-minute move, the Trump administration issues an emergency waiver to ensure millions of people in 55 countries continue receiving life-saving HIV treatment.

PEPFAR, a $7.5 billion initiative established in 2003, has provided HIV care to millions worldwide. The recent suspension of the program raised concerns about the potential loss of access to HIV medications for more than 20 million people.

Secretary of State Marco Rubio’s order to pause nearly all foreign aid has halted funding to the President’s Emergency Plan for AIDS Relief (PEPFAR), an African HIV-prevention program launched by President George W. Bush in 2003 that has saved over 25 million lives.

The action originates from President Trump’s executive order on foreign aid, which he signed on his first day in office last Monday.

The President's Emergency Plan for AIDS Relief has provided life-saving treatment to tens of millions since it was established in 2003

US President Donald Trump recently announced a freeze on an emergency plan for AIDS relief, also known as the President's Emergency Plan for AIDS Relief.

The United States has approved an emergency humanitarian waiver allowing continued access to HIV treatment funded by the U.S. across 55 countries worldwide including Kenya. On January 29, 2025, U.S. Secretary of State Marco Rubio authorized the waiver,

The World Health Organisation (WHO) has expressed deep concern about the funding pause for HIV programmes in low- and middle-income countries.